Trial finds new drug combo increases remission time for lymphoma patientsecancermedicalscienceA trial led by French researchers has found that patients under 60 with a form of non-Hodgkin's lymphoma called 'diffuse large B-cell lymphoma' ar…
Fighting Cancer, Celebrating LifeHuffington PostChemo and a crazy protocol of a drug called Rituximab for two months this summer made me good as new. I thank the men and woman in white lab coats for that and on their behalf, I am writing you. "I t…
ecancermedicalscienceIntensive chemotherapy dramatically improves recurrence and survival in …ecancermedicalscienceYounger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive sign…
Family Practice News Digital NetworkHeart of a Lion: Rheumatologist Holds Fast to His Charitable PlansFamily Practice News Digital NetworkDr. Lee's undertaking is inspired by his beloved aunt, Maureen Rayner, of Bournemouth in the south of England,…
ecancermedicalscienceIntensified Immunochemotherapy Benefits B-Cell LymphomaDoctors LoungeFor patients with untreated diffuse large B-cell lymphoma, intensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and…
ecancermedicalscienceIntense Chemo Best for Aggressive LymphomaMedscapeNovember 29, 2011 — Adding rituximab to a dose-intensive immunochemotherapy regimen significantly improves survival in young patients with diffuse large B cell lymphoma with low-i…
US Oncology Research Affiliated Investigators Participated in Studies that …MarketWatch (press release)"When we presented our data with the Syk inhibitor fostamatinib at the ASH plenary session in 2008, B Cell Receptor signaling inhibitors were …
Talon Therapeutics Announces First Patient Enrolled in the Phase 3 OPTIMAL>60 …MarketWatch (press release)The title of the DSHNHL study is "Improvement of outcome and reduction in toxicity in elderly patients with CD20+ aggressive B-cell lymp…
Intensive chemotherapy aids survivalInsideireland.ieAn intensive course of the medical treatment alongside prescription drug rituximab can double remission time for a younger patient with large B-cell lymphoma. Scientists from French study group Groupe…
Cancer Research UKIntensified Chemo Boosts Survival in B-Cell LymphomaMedPage TodayThe three-year overall survival rate with intensive chemotherapy plus rituximab was 92%, compared with 84% among patients receiving a more conventional chemotherapy regi…